[1]
|
Barkagan, Z.S. and Kotovschikova, E.F. (2004) Comparative analysis of main and side effects of various forms of acetylsalicylic acid. Clinical Pharmacology and Therapy, 13, 1-4.
|
[2]
|
Ketterer, M.W., Brymer, J., Rhoads, K., Kraft, P. and Lovallo, W.R. (1996) Is aspirin, as used for antithrombosis, an emotion-modulating, agent? Journal of Psycho- somatic Re-search, 40, 53-58.
doi:10.1016/0022-3999(95)00524-2
|
[3]
|
Alekseyeva, L.I. (2009) Questions of use of non-steroidal anti-inflammatory drugs in rheumatology practice. Consilium Medicum Ukraina, 3, 3-10.
|
[4]
|
Tochilkina, L.P. (2007) Phenomenon of extremely low doses, homeopathy and organophosphorus agent. Chemical and Biological Safety, 1, 4-14.
|
[5]
|
Ashmarin, I.P., Karazeyeva, Y.P. and Lelekova, T.V. (1999) On the question of development of the problem of effectiveness of extremely low doses of biologically active compounds. Russian Journal of Chemistry, 37, 21- 28.
|
[6]
|
Markel, A.L. (1981) To evaluation of general characteristics of rat behavior in the open field test. Journal of Higher Nervous Activity, 31, 301-307.
|
[7]
|
Porsolt, R.D., Le Pinchon, M. and Jalfre, M. (1977) Depression: A new animal model sensitive to antidepressant treatments. Nature, 266, 730-732. doi:10.1038/266730a0
|
[8]
|
Doutremepuich, C., Aguejouf O., Desplat, V. and Eizay- aga, F.X. (2010) Aspirin therapy: An attempt to explain the events of prothrombotic complications after treatment discontinuation. Thrombosis and Haemostasis, 103, 171- 180. doi:10.1160/TH09-07-0506
|
[9]
|
Yakovchyuk, T.V., Katyushyna, O.V., Husainov, D.R., Korenyuk, I.I., Kolotilova, O.I., Gamma, T.V. and Cheretayev, I.V. (2010) Influence of acetylsalicylic acid, cobalt and zinc aspirinates on rat behavior. Series: Biology, Chemistry, 23, 200-208.
|
[10]
|
Sazanov, L.A. and Zaitsev, S.V. (1992) Effect of superlow doses (10-18-10-16 М) of biologically active substances: General trends, salient features, and possible mechanisms. Biochemistry, 57, 1443-1460.
|
[11]
|
Zhang, J.J., Ding, E.L. and Song, Y.Q. (2006) Adverse effects of cyclooxygenase 2 inhibitors on renal and arrhythmia events. Clinician’s Corner, 296, 1619-1632.
|
[12]
|
Brenneis, C., Maier, T.J., Schmidt, R., et al. (2006) Inhibition of prostaglandin E2 synthesis by SC-560 is independent of cyclooxygenase 1 inhibition. FASEB Journal, 20, 1352-1360. doi:10.1096/fj.05-5346com
|
[13]
|
Chan, F.K. (2002) Celecoxib versus diclofenac and ome-prazole in reducing the risk of recurrent ulcer bleeding in patients with arthritis. New England Journal of Medicine, 347, 2104-2110. doi:10.1056/NEJMoa021907
|
[14]
|
Burlakova, Y.B., Kondratov, A.A. and Khudyakov, I.V. (1990) Exposure to chemical agents at very small doses on biological objects. Bulletin of the Academy of Science of the USSR, Series: Biology, 2, 183-194.
|